BCHE and Alzheimer disease: Currently, the most widely used drugs for the treatment of AD consist of cholinesterase inhibitors and N-methyl-D-aspartic acid receptor antagonists, which can temporarily alleviate the symptoms, but are frequently accompanied by severe side effects, lack disease-modifying efficacy, and some patients are prone to drug resistance [25].